These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. In vitro comparison of cilofungin alone and in combination with other antifungal agents against clinical isolates of Candida species. Smith KR, Lank KM, Dismukes WE, Cobbs CG. Eur J Clin Microbiol Infect Dis; 1991 Jul; 10(7):588-92. PubMed ID: 1655435 [Abstract] [Full Text] [Related]
10. Activity of cilofungin (LY121019) against Candida species in vitro. Odds FC. J Antimicrob Chemother; 1988 Dec; 22(6):891-7. PubMed ID: 3243737 [Abstract] [Full Text] [Related]
11. [Antifungal susceptibility among the isolates of yeast from the University Hospital of the Ryukyus]. Ohta C, Yamane N, Nakasone I, Onaga S, Nakamura K. Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 2005 Dec; 16(2):127-33. PubMed ID: 16536058 [Abstract] [Full Text] [Related]
16. In vitro antifungal activity of FK463, a new water-soluble echinocandin-like lipopeptide. Mikamo H, Sato Y, Tamaya T. J Antimicrob Chemother; 2000 Sep; 46(3):485-7. PubMed ID: 10980180 [Abstract] [Full Text] [Related]
18. Susceptibility of fluconazole-resistant clinical isolates of Candida spp. to echinocandin LY303366, itraconazole and amphotericin B. Cuenca-Estrella M, Mellado E, Díaz-Guerra TM, Monzón A, Rodríguez-Tudela JL. J Antimicrob Chemother; 2000 Sep; 46(3):475-7. PubMed ID: 10980178 [Abstract] [Full Text] [Related]
19. A study of the antifungal activity of LY121019, a new echinocandin derivative. Strippoli V, D'Auria FD, Simonetti N. Chemioterapia; 1988 Feb; 7(1):33-7. PubMed ID: 3288366 [Abstract] [Full Text] [Related]
20. The efficiency of the benzothiazole APB, the echinocandin micafungin, and amphotericin B in fluconazole-resistant Candida albicans and Candida dubliniensis. Melkusová S, Bujdáková H, Volleková A, Myoken Y, Mikami Y. Pharmazie; 2004 Jul; 59(7):573-4. PubMed ID: 15296100 [Abstract] [Full Text] [Related] Page: [Next] [New Search]